185 related articles for article (PubMed ID: 12856722)
1. Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers.
Casey RC; Koch KA; Oegema TR; Skubitz KM; Pambuccian SE; Grindle SM; Skubitz AP
Clin Exp Metastasis; 2003; 20(4):343-56. PubMed ID: 12856722
[TBL] [Abstract][Full Text] [Related]
2. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.
Burleson KM; Hansen LK; Skubitz AP
Clin Exp Metastasis; 2004; 21(8):685-97. PubMed ID: 16035613
[TBL] [Abstract][Full Text] [Related]
3. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.
Lessan K; Aguiar DJ; Oegema T; Siebenson L; Skubitz AP
Am J Pathol; 1999 May; 154(5):1525-37. PubMed ID: 10329605
[TBL] [Abstract][Full Text] [Related]
4. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.
Casey RC; Skubitz AP
Clin Exp Metastasis; 2000; 18(1):67-75. PubMed ID: 11206841
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases-2 and -9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma.
Sakata K; Shigemasa K; Uebaba Y; Nagai N; Ohama K
Acta Cytol; 2002; 46(4):697-703. PubMed ID: 12146034
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
[TBL] [Abstract][Full Text] [Related]
8. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
10. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
11. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis.
Davidowitz RA; Iwanicki MP; Brugge JS
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371143
[TBL] [Abstract][Full Text] [Related]
12. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
13. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.
Fishman DA; Kearns A; Chilukuri K; Bafetti LM; O'Toole EA; Georgacopoulos J; Ravosa MJ; Stack MS
Invasion Metastasis; 1998; 18(1):15-26. PubMed ID: 10207247
[TBL] [Abstract][Full Text] [Related]
14. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
15. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium.
Stadlmann S; Feichtinger H; Mikuz G; Marth C; Zeimet AG; Herold M; Knabbe C; Offner FA
Int J Gynecol Cancer; 2014 Feb; 24(2):192-200. PubMed ID: 24407573
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma.
Ripley D; Tunuguntla R; Susi L; Chegini N
Int J Gynecol Cancer; 2006; 16(5):1794-800. PubMed ID: 17009974
[TBL] [Abstract][Full Text] [Related]
18. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D
Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.
Park DW; Ryu HS; Choi DS; Park YH; Chang KH; Min CK
Gynecol Oncol; 2001 Sep; 82(3):442-9. PubMed ID: 11520138
[TBL] [Abstract][Full Text] [Related]
20. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
